MK

Muskan Kumawat

Active Director Additional Director DIN 10624158
DIN 10624158 First appointment May 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value •••• Premium profile

About Muskan Kumawat

Data last updated:

Muskan Kumawat is an Additional Director at Aprikose Pharmaceuticals Private Limited (since 2024). The company operates in Pharma. Aprikose Pharmaceuticals Private Limited reported revenue of ₹74.2 Lakh (FY 2019).

DIN 10624158
Primary Designation Additional Director
Industry Pharma
First Appointment 11 May 2024
Oldest Company Age 10 yrs
Largest company Aprikose Pharmaceuticals Private Limited · ₹74.2 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director11 May 20242016₹74.2 Lakh (FY 2019)Active

Board colleagues of Muskan Kumawat

NameDINCompanyDesignation
Harish Dublad07486169Aprikose Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aprikose Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Muskan Kumawat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Muskan Kumawat

Muskan Kumawat currently holds 1 directorship: Aprikose Pharmaceuticals Private Limited (Additional Director, since 11 May 2024, revenue ₹74.2 Lakh (FY 2019)).

Muskan Kumawat was first appointed on 11 May 2024 as Additional Director at Aprikose Pharmaceuticals Private Limited.

The current boards of Muskan Kumawat's companies include Harish Dublad (Aprikose Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available